Theriva Biologics (TOVX) Total Debt (2022 - 2026)
Theriva Biologics (TOVX) posted quarterly Total Debt of $2.8 million for Q1 2026, up 81.29% year-over-year from $1.6 million in Q1 2025, and up 63.14% quarter-over-quarter from $1.7 million in Q4 2025.
Theriva Biologics (TOVX) Total Debt (2022 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Total Debt for 5 consecutive years, with $2.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt rose 81.29% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 81.29% YoY), while the FY2025 annual figure was $1.7 million, up 1029.41% from the prior year.
- Total Debt grew to $2.8 million in Q1 2026 per TOVX's latest filing, from $1.7 million in the prior quarter.
- Across five years, Total Debt topped out at $8.8 million in Q3 2022 and bottomed at $153000.0 in Q4 2024.
- Historically, Total Debt has averaged $2.0 million across 5 years, with a median of $297000.0 in 2022.
- Annual changes were most pronounced in 2023 — Total Debt plunged 97.56% — and 2025, when it surged 1029.41%.
- Theriva Biologics' Total Debt stood at $278000.0 in 2022, then declined by 19.06% to $225000.0 in 2023, then slumped by 32.0% to $153000.0 in 2024, then soared by 1029.41% to $1.7 million in 2025, then soared by 63.14% to $2.8 million in 2026.
- Business Quant data shows TOVX's Total Debt at $2.8 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.34 Bn |
| 10 | Theriva Biologics | 10.97 Mn | 10.97 Mn | - | 4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 2.82 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 153,000.00 |
| Sep 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 155,000.00 |
| Mar 31, 2024 | 221,000.00 |
| Dec 31, 2023 | 225,000.00 |
| Sep 30, 2023 | 215,000.00 |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 278,000.00 |
| Sep 30, 2022 | 8.82 Mn |
| Jun 30, 2022 | 8.67 Mn |
| Mar 31, 2022 | 297,000.00 |